Preoperative motor deficits and depressive symptoms predict quality of life in patients with Parkinson’s disease at different time points after surgery for subthalamic stimulation: a retrospective study
-
Published:2024-02-08
Issue:1
Volume:6
Page:
-
ISSN:2524-3489
-
Container-title:Neurological Research and Practice
-
language:en
-
Short-container-title:Neurol. Res. Pract.
Author:
Semmler CarolinORCID, Stopic Vasilija, Jost Stefanie T., Fink Gereon R., Weiss Peter H., Barbe Michael T.
Abstract
Abstract
Background
While subthalamic nucleus deep brain stimulation (STN-DBS) improves the quality of life (QoL) of patients with Parkinson’s disease (PD), the clinical parameters that predict this improvement remain debated. This retrospective study explored whether preoperative motor, cognitive, and affective parameters predict QoL or its components at 6 and 12 months after STN-DBS surgery.
Methods
QoL was assessed with the Parkinson’s Disease Questionnaire-39 (PDQ-39) before (baseline), at 6 months (N = 90) and 12 months (N = 63) after STN-DBS surgery. Changes in the PDQ-39 and its subdomains were analysed with Wilcoxon signed-rank tests. In total, seven motor, cognitive, and affective parameters recorded at baseline were used in multiple linear regressions to predict QoL and its subdomains.
Results
QoL had improved significantly at six months post STN-DBS surgery. After 12 months, this effect remained significant but was less pronounced. At both time points, significant improvements in mobility, activities of daily living, stigma, and bodily discomfort were present. Correlation and linear regression analyses showed that preoperative QoL status and changes in QoL at 6 and 12 months after surgery were driven by preoperative dopaminergic medication, as well as motor (UPDRS-III medOFF and PIGD-subscore medOFF) and affective (HADS anxiety and depression) symptoms. In contrast, preoperative cognitive performance did not predict QoL at any time point.
Conclusion
Data show that preoperative motor and affective symptoms drive both QoL baseline status and changes in QoL after STN-DBS surgery. Thus, these clinical parameters need to be assessed appropriately to provide comprehensive presurgical advice to patients suffering from PD.
Funder
Deutsche Forschungsgemeinschaft Universität zu Köln
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Opara, J. (2003). Current possibilities of evaluation of quality of life in Parkinson disease. Neurologia i Neurochirurgia Polska, 37, 241–250. 2. Blahak, C., Bäzner, H., Capelle, H. H., Wöhrle, J. C., Weigel, R., Hennerici, M. G., & Krauss, J. K. (2009). Rapid response of parkinsonian tremor to STN-DBS changes: Direct modulation of oscillatory basal ganglia activity? Movement Disorders, 24(8), 1221–1225. 3. Oyama, G., Foote, K. D., Jacobson, C. E., IV., Velez-Lago, F., Go, C., Limotai, N., Zeilman, P. R., Romrell, J., Wu, S. S., & Neal, D. (2012). GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson’s disease. Parkinsonism Related Disorders, 18(7), 814–818. 4. Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., & Eisner, W. (2006). A randomized trial of deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine, 355(9), 896–908. 5. Lachenmayer, M. L., Mürset, M., Antih, N., Debove, I., Muellner, J., Bompart, M., Schlaeppi, J.-A., Nowacki, A., You, H., & Michelis, J. P. (2021). Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—Meta-analysis of outcomes. NPJ Parkinson’s Disease, 7(1), 1–10.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|